secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001522767-24-000005
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q4 revenue $38.9M (+8.6% YoY); GAAP net loss $10.1M; announces MD dispensary acquisition
--------------------------------------------------------------------------------

- Q4 2023 revenue $38.9M, up 8.6% from $35.8M in Q4 2022; full year revenue $148.6M, up 10.9% from $134.0M.
- GAAP net loss of $10.1M in Q4 vs net income of $4.8M in prior year; full year net loss $16.0M vs net income $13.6M.
- Non-GAAP adjusted EBITDA $5.2M in Q4 (14% margin) vs $4.5M in Q4 2022; full year $24.7M (17% margin) vs $32.4M (24% margin).
- Company announces pending acquisition of a dispensary in Upper Marlboro, Maryland, expanding its footprint in the state.
- CEO cites sixth consecutive year of double-digit revenue growth and positive adjusted EBITDA; wholesale operations in Illinois contributing to 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/0001522767-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276724000005/mrmd-20240306.htm
  HTML page:      https://secwatch.observer/filing/0001522767-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer